Streetbeat News

Products Services

AMZN

Amazon showcased its advancements in robotics at the 'Delivering the Future' event, focusing on drone deliveries and warehouse automation. The company announced the expansion of its Prime Air service, with drone deliveries of medications from Amazon Pharmacy to customers in College Station, Texas. The drone delivery service is also expected to launch in another U.S. city and select locations in the U.K. and Germany next year. Amazon also introduced Sequoia, a system to enhance inventory management at fulfillment centers, which can process inventory up to 75% faster and reduce order processing time by 25%.

Portfolio Pulse from Anusuya Lahiri

October 30, 2023 | 4:09 pm

HPE

Hewlett Packard Enterprise (HPE) has announced that Żabka, the largest convenience store chain in Poland and Central and Eastern Europe, has selected the HPE GreenLake edge-to-cloud platform to run its SAP S/4HANA applications. The platform will provide Żabka with enhanced performance, availability, scalability, and predictable usage-based pricing to support its expansion. The chain operates at almost 10,000 locations and opens 1,000 new stores annually on average.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 4:04 pm

STKT

Israeli technology and cannabinoid company StickIt Ltd., a subsidiary of StickIt Technologies Inc., has debuted on the Canadian Securities Exchange (CSE) under the ticker symbol 'STKT'. The company, known for its toothpick-sized cannabis products, is also developing a new line of products for the non-smoking industry, including a unique cold drinking straw and a hot drink shaker stick containing cannabinoids.

Portfolio Pulse from Jelena Martinovic

October 30, 2023 | 3:59 pm

CVS

GSK

PFE

GSK has taken an early lead in the respiratory syncytial virus (RSV) vaccine market, surpassing Pfizer. This success is attributed to GSK's strategic partnership with CVS Health Corp, the largest pharmacy chain in the U.S. GSK's RSV vaccine accounts for nearly two-thirds of RSV shots administered since early September. The vaccine is also listed at a slight discount compared to Pfizer's offering, which may be influencing independent pharmacists' decisions.

Portfolio Pulse from Vandana Singh

October 30, 2023 | 3:48 pm

RVPH

Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) announced positive results from its Phase 3 RECOVER trial evaluating brilaroxazine, a drug for adults with schizophrenia. The trial met its primary endpoint, showing a significant reduction in symptom severity. The company expects to report further data from the ongoing trial in Q4 2024 and initiate a new trial in Q1 2024. The data will potentially support a planned NDA submission to the FDA in 2025. RVPH shares are up 5.33% following the announcement.

Portfolio Pulse from Vandana Singh

October 30, 2023 | 3:45 pm

DCPH

Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) announced positive results from the MOTION Phase 3 study of vimseltinib in patients with Tenosynovial Giant Cell Tumor (TGCT). The study met its primary endpoint, demonstrating significant improvement versus placebo. The company plans to submit a marketing application to the FDA for vimseltinib in Q2 2024. Q3 revenues were $43.31 million, up 20%, beating the consensus of $39.35 million. DCPH shares are up 21.60% at $12.35.

Portfolio Pulse from Vandana Singh

October 30, 2023 | 3:22 pm

NVS

Novartis AG has released positive interim results from its Phase 3 ALIGN study of atrasentan, a drug for IgA nephropathy (IgAN), a major cause of chronic kidney disease. The drug demonstrated a significant reduction in proteinuria in patients with IgAN. Novartis plans to submit an application for possible accelerated approval in the US in 2024. The company's shares are up 1.68% at $93.82.

Portfolio Pulse from Vandana Singh

October 30, 2023 | 3:18 pm

CHRS

Coherus BioSciences, Inc. (NASDAQ:CHRS) shares are trading higher after the company announced the FDA-approval of Loqtorzi, a treatment for recurrent or metastatic nasopharyngeal carcinoma. This approval is a significant event for Coherus, marking it as an innovative oncology company. The company's shares have attracted attention from retail investors and short-sellers, with CHRS being one of the top trending tickers on Yahoo Finance. The stock's trading volume has significantly increased, with more than 13.7 million shares traded compared to the 100-day average of 2.853 million shares.

Portfolio Pulse from Erica Kollmann

October 30, 2023 | 3:04 pm

SHOT

Safety Shot has announced the direct-to-consumer launch of its product in the first week of December 2023, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 3:01 pm

BTAI

BioXcel Therapeutics announced that the Centers for Medicare & Medicaid Services has issued a permanent and product-specific J-Code for IGALMI sublingual film, leading to a rise in the company's shares.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 2:59 pm